(Q43959465)

English

Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes

scientific article published in December 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

circulatory system

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Ahmad Haidar

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Aksam Yassin

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Farid Saad

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Ridwan Shabsigh

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

1 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

189-196

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Gonadotropin-releasing hormone agonists in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Body mass index as a predictor of prostate cancer: development versus detection on biopsy

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Relationship between obesity and prostate cancer

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE.

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Marked hyperglycemia after androgen-deprivation therapy for prostate cancer and usefulness of pioglitazone for its treatment

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

The Clinical Significance of PPAR Gamma Agonism

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Diabetes mellitus is associated with subnormal serum levels of free testosterone in men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Testosterone concentrations in women and men with NIDDM.

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

The pituitary-gonadal axis and health in elderly men: a study of men born in 1913.

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

The associations of endogenous testosterone and sex hormone-binding globulin with glycosylated hemoglobin levels, in community dwelling men. The Tromsø Study

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Insulin resistance, body fat distribution, and sex hormones in men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Sex steroid hormones, upper body obesity, and insulin resistance.

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

The decline of androgen levels in elderly men and its clinical and therapeutic implications

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Endogenous sex hormones and metabolic syndrome in aging men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

HYPOGONADISM AND METABOLIC SYNDROME: IMPLICATIONS FOR TESTOSTERONE THERAPY

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Androgens, insulin resistance and vascular disease in men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Contribution of age and declining androgen levels to features of the metabolic syndrome in men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Mitochondrial dysfunction in the elderly: possible role in insulin resistance

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Estradiol in elderly men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Effects on the endocrine system of long-term treatment with the luteinizing hormone-releasing hormone agonist leuprolide in patients with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Estrogens in males: what have we learned in the last 10 years?

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Effects of estrogen replacement therapy on bone and glucose metabolism in a male with congenital aromatase deficiency

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Low serum testosterone and mortality in male veterans

1 reference

https://api.crossref.org/works/10.1080%2F13685530701653538

21 January 2018

Identifiers

10.1080/13685530701653538

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43959465&oldid=2122223403"